Biochemical Changes in Blood of Patients with Duchenne Muscular Dystrophy Treated with Granulocyte-Colony Stimulating Factor.

Conclusions: G-SCF decreased the aminotransferases activity, cholesterol level, and glucose level in patients with DMD, which may be important for patients with DMD and metabolic syndrome.
PMID: 31001554 [PubMed - in process]

Source: Biomed Res - April 21, 2019 Category: Research Authors: Sienkiewicz D, Kułak W, Paszko-Patej G, Okurowska-Zawada B, Sienkiewicz J, Kułak P Tags: Biomed Res Int Source Type: research